AB 45 – Industrial Hemp Extracts in California: CBD and More!
The Gist: Assembly Bill 45, which is headed to the governor’s desk, expressly allows the sale of hemp-derived extracts, like CBD, that comply with testing and labeling standards. Although CBD products are already found in stores, these products are considered “adulterated” under existing California law. (Sherman Food, Drug, and Cosmetic Law.) AB 45 will create clarity for the industry and reassure consumers that products are tested by independent laboratories and properly labeled.
Key Points:
If AB 45 is signed by Gov. Newsom, hemp product manufacturers must:
- Register with the California Department of Public Health (CDPH) and comply with good manufacturing practices.
- Test extracts to ensure total THC does not exceed 0.3% and max cannabis contaminant levels.
- Link product labels to lab testing results for THC and other cannabinoids, and avoid untrue health related claims.
- Demonstrate their hemp is grown in a state or country that has an established industrial hemp program.
- Avoid marketing to children or pregnant women.
CDPH will be the primary regulatory agency and may regulate maximum serving sizes and adopt recordkeeping standards. The bill also directs CDPH to study the introduction of hemp cannabinoids into the cannabis supply chain.
What Products Will Be Allowed?
The following products containing hemp derivatives will be allowed to be manufactured and sold in California:
- Food
- Beverages
- Dietary Supplements
- Cosmetics
- Pet Food
- Inhalable products (can be manufactured and sold outside of California, but may not be sold in California until a tax is enacted)
Hemp derivatives are not allowed in alcoholic beverages or tobacco products.
Next Steps:
This bill is an emergency statute and will go into effect immediately if signed by the governor. Once federal law is clarified pertaining to hemp-derived products, new regulations may be adopted as necessary to conform with federal law.
Contributors:
Recent Insights
Read MoreUnderstanding of Withdrawal Liability
Client Alert | November 10, 2025U.S. Expands Critical Minerals Financing and Bilateral Partnerships Under Trump
Client Alert | November 06, 2025Election 2025: Pennsylvania Judicial Retention
Client Alert | November 06, 2025Election 2025: California’s Prop 50 Passes
Client Alert | November 06, 2025Election 2025: What to Watch From Other Notable Races
Client Alert | November 06, 2025Election 2025: New Jersey Gubernatorial and Legislative Elections
You have chosen to send an email to Brownstein Hyatt Farber Schreck or one of its lawyers. The sending and receipt of this email and the information in it does not in itself create and attorney-client relationship between us.
If you are not already a client, you should not provide us with information that you wish to have treated as privileged or confidential without first speaking to one of our lawyers.
If you provide information before we confirm that you are a client and that we are willing and able to represent you, we may not be required to treat that information as privileged, confidential, or protected information, and we may be able to represent a party adverse to you and even to use the information you submit to us against you.
I have read this and want to send an email.